 |
市場調查報告書
商品編碼
1481327
手持式超音波心動圖設備市場- 按產品（診斷[靜止、壓力]、監測[穿戴式、MCT]）、導極類型（單導聯、3 導聯、6 導程、12 導程）、最終用途（醫院、診所、診斷中心、 ASC) - 全球預測，2024 - 2032Handheld Echocardiography Devices Market - By Product (Diagnostics [Resting, Stress], Monitoring [Wearable, MCT]), Lead Type (Single Lead, 3 Lead, 6 Lead, 12 Lead), End-use (Hospitals, Clinics, Diagnostic Centers, ASCs) - Global Forecast, 2024 - 2032 |
||||||
受心血管疾病(CVD) 盛行率上升、手持式超音波心動圖設備技術進步以及人們對早期檢測和監測心臟病意識不斷增強的推動，全球手持式超音波心動圖設備市場在2024 年至2032 年期間將以4.5% 的複合年成長率成長。
據世界衛生組織稱，心血管疾病每年奪走約 1,790 萬人的生命，成為全球死亡的主要原因。由於心血管疾病在全球死亡率中佔相當大的比例，因此迫切需要有效的診斷工具來實現早期發現和介入。手持式超音波心動圖設備為醫療保健專業人員提供了一種攜帶式且易於使用的解決方案，可以及時進行心臟評估，從而促進心血管疾病的主動管理。在久坐的生活方式、不健康的飲食習慣和人口老化等因素的推動下，全球心血管疾病的負擔持續升級，手持式超音波心動圖設備的需求預計將猛增，推動未來幾年的市場成長。
手持式超音波心動圖設備產業根據產品、引線類型、最終用途和地區進行分類。
到 2032 年，監測領域將出現顯著成長，因為超音波心動圖設備可以在從重症監護室到門診診所的各種臨床環境中連續監測心臟功能。感測器技術和資料分析的進步使得手持設備的開發能夠提供全面的血流動力學評估，包括心輸出量、射血分數和瓣膜功能的測量，從而促進細分市場的成長。
由於手持式超音波心動圖設備卓越的成像能力和診斷準確性，到 2032 年，三導聯手持式超音波心動圖設備市場佔有率將大幅成長。這些設備利用先進的換能器技術和複雜的演算法來即時產生心臟的3D影像，為臨床醫生提供心臟解剖和功能無與倫比的見解。從多個角度可視化心臟結構的能力增強了診斷信心，同時促進更精確的治療計劃，特別是在先天性心臟缺陷和結構性心臟病等複雜病例中。
在快速城市化、擴大醫療基礎設施和增加醫療支出的推動下，亞太地區手持式超音波心動圖設備產業將在 2024 年至 2032 年間以良好的速度成長。中國、印度和日本等國家的心血管疾病負擔日益加重，對先進診斷解決方案產生了巨大需求。此外，旨在改善醫療服務取得和促進預防心臟病學的政府措施進一步推動了該地區的市場成長。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 遠距患者監護的需求不斷增加
- 技術進步
- 心血管疾病發生率上升
- 人口老化加劇和家庭醫療保健趨勢
- 產業陷阱與挑戰
- 法規遵從性和標準化
- 與傳統心電圖系統相比，診斷能力有限
- 成長動力
- 成長潛力分析
- 監管環境
- 技術景觀
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司市佔率分析
- 競爭定位矩陣
- 戰略展望矩陣
第 5 章：市場估計與預測：按產品分類，2018 年 - 2032 年
- 主要趨勢
- 診斷心電圖機
- 靜止心電圖
- 壓力心電圖
- 監護心電圖設備
- 動態心電圖監測儀
- 移動心臟遙測 (MCT)
- 穿戴式心電圖設備
- 其他設備
第 6 章：市場估計與預測：按鉛類型，2018 - 2032 年
- 主要趨勢
- 單引線型
- 3引線型
- 6引線型
- 12引線型
- 其他引線類型
第 7 章：市場估計與預測：按最終用途，2018 - 2032 年
- 主要趨勢
- 醫院和診所
- 診斷中心
- 門診手術中心
- 家庭護理設置
- 其他最終用戶
第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區
第 9 章：公司簡介
- AliveCor, Inc.
- Allengers Medical Systems, Ltd.
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Fukuda Denshi Co., Ltd.
- GE HealthCare Technologies Inc.
- Hill-Rom Holdings, Inc.
- Koninklijke Philips N.V.
- Medtronic plc
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Global Handheld Echocardiography Devices Market will grow at 4.5% CAGR during 2024-2032, driven by the rising prevalence of cardiovascular diseases (CVDs), technological advancements in handheld echocardiography devices, and growing awareness of early detection and monitoring of cardiac conditions.
According to WHO, cardiovascular diseases claim approximately 17.9 million lives annually, becoming the primary cause of death worldwide. With CVDs accounting for a considerable portion of global mortality rates, there is an urgent need for efficient diagnostic tools to enable early detection and intervention. Handheld echocardiography devices offer a portable and accessible solution for healthcare professionals to conduct timely cardiac assessments, thereby facilitating proactive management of CVDs. As the burden of cardiovascular diseases continues to escalate worldwide, fueled by factors such as sedentary lifestyles, unhealthy dietary habits, and aging populations, the demand for handheld echocardiography devices is expected to soar, driving market growth in the coming years.
The Handheld Echocardiography Devices Industry is classified based on product, lead type, end-use, and region.
The monitoring segment will register significant growth by 2032, as echocardiography devices allow for continuous monitoring of cardiac function in various clinical settings, ranging from intensive care units to outpatient clinics. Advancements in sensor technology and data analytics have enabled the development of handheld devices capable of providing comprehensive hemodynamic assessments, including measurement of cardiac output, ejection fraction, and valve function, thereby enhancing segment growth.
The handheld echocardiography devices market share from the 3 leads segment will grow substantially through 2032 due to the superior imaging capabilities and diagnostic accuracy of handheld echocardiography devices. These devices utilize advanced transducer technology and sophisticated algorithms to generate three-dimensional images of the heart in real time, offering clinicians unparalleled insights into cardiac anatomy and function. The ability to visualize cardiac structures from multiple angles enhances diagnostic confidence while facilitating more precise treatment planning, particularly in complex cases such as congenital heart defects and structural heart diseases.
Asia Pacific Handheld Echocardiography Devices Industry will grow at a decent pace between 2024 and 2032, driven by rapid urbanization, expanding healthcare infrastructure, and increasing healthcare expenditure. Countries such as China, India, and Japan are witnessing a growing burden of cardiovascular diseases, creating a significant demand for advanced diagnostic solutions. Moreover, government initiatives aimed at improving access to healthcare services and promoting preventive cardiology are further fueling market growth in the region.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing demand for remote patient monitoring
- 3.2.1.2 Advancements in technology
- 3.2.1.3 Rising cardiovascular disease incidence
- 3.2.1.4 Increasing aging population and home healthcare trends
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Regulatory compliance and standardization
- 3.2.2.2 Limited diagnostic capability compared to traditional ECG systems
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Diagnostics ECG machines
- 5.2.1 Resting ECG
- 5.2.2 Stress ECG
- 5.3 Monitoring ECG devices
- 5.3.1 Holter monitors
- 5.3.2 Mobile cardiac telemetry (MCT)
- 5.3.3 Wearable ECG devices
- 5.3.4 Other devices
Chapter 6 Market Estimates and Forecast, By Lead Type, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Single lead type
- 6.3. 3 lead type
- 6.4. 6 lead type
- 6.5. 12 lead type
- 6.6 Other lead types
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals & clinics
- 7.3 Diagnostic centers
- 7.4 Ambulatory surgical centers
- 7.5 Home care settings
- 7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 AliveCor, Inc.
- 9.2 Allengers Medical Systems, Ltd.
- 9.3 Biotronik SE & Co. KG
- 9.4 Boston Scientific Corporation
- 9.5 Fukuda Denshi Co., Ltd.
- 9.6 GE HealthCare Technologies Inc.
- 9.7 Hill-Rom Holdings, Inc.
- 9.8 Koninklijke Philips N.V.
- 9.9 Medtronic plc
- 9.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
